Access the full text.
Sign up today, get DeepDyve free for 14 days.
(2003)
Mol Cell Biol 23: 150–162
J. Garrus, U. Schwedler, O. Pornillos, S. Morham, K. Zavitz, Hubert Wang, D. Wettstein, Kirsten Stray, M. Côté, R. Rich, D. Myszka, W. Sundquist (2001)
Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 BuddingCell, 107
R. Jessberger (2002)
The many functions of smc proteins in chromosome dynamicsNature Reviews Molecular Cell Biology, 3
Yu-min Lin, Y. Furukawa, T. Tsunoda, C. Yue, Kou-Ching Yang, Yusuke Nakamura (2002)
Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomasOncogene, 21
N. Bishop, P. Woodman (2001)
TSG101/Mammalian VPS23 and Mammalian VPS28 Interact Directly and Are Recruited to VPS4-induced Endosomes*The Journal of Biological Chemistry, 276
Zijie Sun, Jing Pan, G. Bubley, S. Balk (1997)
Frequent abnormalities of TSG101 transcripts in human prostate cancerOncogene, 15
C. Gridelli, A. Rossi, P. Maione (2003)
Treatment of non-small-cell lung cancer: state of the art and development of new biologic agentsOncogene, 22
T. Kikuchi, Y. Daigo, T. Katagiri, T. Tsunoda, Koichi Okada, S. Kakiuchi, H. Zembutsu, Y. Furukawa, M. Kawamura, Koichi Kobayashi, K. Imai, Yusuke Nakamura (2003)
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugsOncogene, 22
Limin Li, Stanley Cohen (1996)
tsg101: A Novel Tumor Susceptibility Gene Isolated by Controlled Homozygous Functional Knockout of Allelic Loci in Mammalian CellsCell, 85
L. Saltz, J. Cox, C. Blanke, L. Rosen, L. Fehrenbacher, M. Moore, J. Maroun, S. Ackland, P. Locker, N. Pirotta, G. Elfring, L. Miller (2000)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.The New England journal of medicine, 343 13
(2000)
Lancet 355: 1041–1047
J. Douillard, D. Cunningham, A. Roth, M. Navarro, R. James, P. Karásek, P. Jandík, T. Iveson, J. Carmichael, M. Alakl, G. Gruia, L. Awad, P. Rougier (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 355
K. Obama, Katsuaki Ura, Meihua Li, T. Katagiri, T. Tsunoda, A. Nomura, S. Satoh, Yusuke Nakamura, Y. Furukawa (2005)
Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinomaHepatology, 41
G. Walt (2004)
WHO's World Health Report 2003BMJ : British Medical Journal, 328
W. Xie, Limin Li, S. Cohen (1998)
Cell cycle-dependent subcellular localization of the TSG101 protein and mitotic and nuclear abnormalities associated with TSG101 deficiency.Proceedings of the National Academy of Sciences of the United States of America, 95 4
(2002)
Oncogene 21: 4120–4128
(2000)
N Engl J Med 343: 905–914
G. Zhu, R. Gilchrist, N. Borley, H. Chng, M. Morgan, J. Marshall, R. Camplejohn, Gordon Muir, I. Hart (2004)
Reduction of TSG101 protein has a negative impact on tumor cell growthInternational Journal of Cancer, 109
Toru Nakamura, Y. Furukawa, H. Nakagawa, T. Tsunoda, H. Ohigashi, K. Murata, O. Ishikawa, K. Ohgaki, Nobuichi Kashimura, M. Miyamoto, S. Hirano, S. Kondo, H. Katoh, Yusuke Nakamura, T. Katagiri (2004)
Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissectionOncogene, 23
M. O'Dwyer, B. Druker (2000)
Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemiaCurrent Opinion in Oncology, 12
(2002)
Cancer Res 62: 7012–7017
K. Wagner, A. Krempler, Yongyue Qi, KyungRan Park, M. Henry, A. Triplett, G. Riedlinger, E. Rucker, L. Hennighausen (2003)
Tsg101 Is Essential for Cell Growth, Proliferation, and Cell Survival of Embryonic and Adult TissuesMolecular and Cellular Biology, 23
Limin Li, Jian Liao, Jürgen Ruland, T. Mak, Stanley Cohen (2001)
A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.Proceedings of the National Academy of Sciences of the United States of America, 98 4
After analysing gene-expression profiles of colon cancers on a cDNA microarray containing cDNAs corresponding to 23 040 human genes, we focused on a gene annotated as C10orf3 (chromosome 10 open reading frame 3), whose expression was elevated in colorectal cancers (CRC) as well as in tumors arising in the stomach, lung, pancreas, and breast. The gene encodes a putative 464-amino-acid protein containing a domain known as AAA (ATPases associated with a variety of cellular activities). Western blot analysis using an antibody to the gene product confirmed that the protein was overexpressed in nine of the 15 clinical cancer tissues examined, compared to corresponding noncancerous epithelial cells. A subsequent proteomics analysis revealed that C10orf3 product associated with the product of tumor susceptibility gene 101 (TSG101), and that C10orf3 downregulated TSG101 in a post-transcriptional manner. Expression of short interfering RNA in cells derived from CRC caused significant decreases in C10orf3 expression and inhibited growth of the transfected cells, which was associated with increased apoptotic cells. These data suggest that elevated C10orf3 expression might play an essential role in the growth of cancer cells, and that suppression of C10orf3-mediated signal transduction may be a novel therapeutic strategy to a wide range of human tumors.
Oncogene – Springer Journals
Published: Sep 19, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.